 "Bharat Biotech, Covaxin")
The World Health Organization’s (WHO's) Technical Advisory Group (TAG) is expected to convene next week to carry out a risk-benefit assessment and come to a final decision on whether to grant emergency-use listing (EUL) to Bharat Biotech’s Covaxin.
A spokesperson for WHO told Business Standard that the EUL decision on Covaxin is still pending. “Bharat Biotech has been submitting the data to WHO on a rolling basis and submitted additional information at WHO’s request on September 27.”
WHO experts are currently reviewing this information. If it addresses all questions raised, WHO-TAG will carry out a risk-benefit assessment and come to
